← Scroll for more →
Caribou Biosciences, Inc. (CRBU)
Biological Products, (No Diagnostic Substances)
Latest Price
$1.27
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.99
P/B Ratio
1.28
Institutional Ownership
44.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7.82M | $13.0M | 7.37% | +5.67M | 2026-06-30 |
| Pfizer Inc | 4.69M | $7.0M | 4.43% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 4.21M | $7.0M | 3.97% | +441.3K | 2026-06-30 |
| Mackenzie Financial Corp | 3.65M | $6.0M | 3.44% | +2.71M | 2026-06-30 |
| Renaissance Technologies LLC | 2.77M | $4.0M | 2.62% | +183.0K | 2026-06-30 |
| Kynam Capital Management, LP | 2.50M | $4.0M | 2.36% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 2.37M | $4.0M | 2.24% | +1.36M | 2026-06-30 |
| State Street Corp | 1.63M | $2.0M | 1.54% | +1.21M | 2026-06-30 |
| Bank of America Corp | 1.41M | $2.0M | 1.33% | +113.8K | 2026-06-30 |
| Two Sigma Investments, LP | 1.05M | $1.0M | 0.99% | -- | 2026-06-30 |